CLIMB BIO, INC. Foreign Currency Transaction Gain (Loss), before Tax
CLIMB BIO, INC. (CLYM) reported Foreign Currency Transaction Gain (Loss), before Tax of $6.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $6.00K.
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$25.00K.
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$46.00K.
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$33.00K, a 163.46% decline year-over-year.
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$291.00K.
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$9.00K, a 102.96% decline from fiscal 2023.
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $304.00K.
- CLIMB BIO, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$408.00K, a 266.53% decline from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.00K 10-Q · filed 2026-08-06 | -$19.00K 10-Q · filed 2026-08-06 | -$65.00K derived: sum of 3 quarters · filed 2026-08-06 | -$98.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$25.00K 10-Q · filed 2026-05-07 | -$71.00K derived: sum of 2 quarters · filed 2026-05-07 | -$104.00K derived: sum of 3 quarters · filed 2026-05-07 | -$266.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$79.00K derived: sum of 2 quarters · filed 2026-03-05 | -$241.00K derived: sum of 3 quarters · filed 2026-08-06 | -$291.00K 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$33.00K 10-Q · filed 2025-11-06 | -$195.00K derived: sum of 2 quarters · filed 2026-08-06 | -$245.00K 10-Q · filed 2025-11-06 | -$271.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$162.00K 10-Q · filed 2026-08-06 | -$212.00K 10-Q · filed 2026-08-06 | -$238.00K derived: sum of 3 quarters · filed 2026-08-06 | -$186.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$50.00K 10-Q · filed 2026-05-07 | -$24.00K 10-Q · filed 2025-05-14 | -$76.00K derived: sum of 2 quarters · filed 2026-05-07 | -$24.00K derived: sum of 3 quarters · filed 2026-05-07 | -$26.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $26.00K derived: sum of 2 quarters · filed 2026-03-05 | $24.00K derived: sum of 3 quarters · filed 2026-03-05 | -$9.00K 10-K · filed 2026-03-05 | $42.00K 10-K · filed 2025-03-25 | |||
| 2024-09-30 | $52.00K 10-Q · filed 2025-11-06 | $50.00K derived: sum of 2 quarters · filed 2025-11-06 | $17.00K 10-Q · filed 2025-11-06 | $99.00K 10-Q · filed 2024-11-12 | -$308.00K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$2.00K 10-Q · filed 2025-08-12 | -$35.00K 10-Q · filed 2025-08-12 | -$9.00K 10-Q · filed 2024-08-14 | -$360.00K derived: sum of 3 quarters · filed 2025-08-12 | -$356.00K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$28.00K 10-Q · filed 2025-05-14 | -$358.00K derived: sum of 2 quarters · filed 2025-05-14 | -$354.00K derived: sum of 3 quarters · filed 2025-05-14 | $45.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$326.00K derived: sum of 2 quarters · filed 2025-03-25 | $73.00K derived: sum of 3 quarters · filed 2025-03-25 | $304.00K 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $403.00K derived: sum of 2 quarters · filed 2024-11-12 | $634.00K 10-Q · filed 2024-11-12 | $2.45M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $399.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $630.00K 10-Q · filed 2024-08-14 | $2.44M derived: sum of 3 quarters · filed 2024-08-14 | $1.45M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $231.00K 10-Q · filed 2024-05-15 | $2.04M derived: sum of 2 quarters · filed 2024-05-15 | $1.05M derived: sum of 3 quarters · filed 2024-05-15 | $0.00 derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $820.00K derived: sum of 2 quarters · filed 2024-03-28 | -$231.00K derived: sum of 3 quarters · filed 2024-03-28 | -$408.00K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$992.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.04M derived: sum of 2 quarters · filed 2023-11-14 | -$2.22M 10-Q · filed 2023-11-14 | -$2.22M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.23M 10-Q · filed 2023-08-10 | -$1.23M derived: sum of 3 quarters · filed 2023-08-10 | -$1.15M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$177.00K 10-Q · filed 2023-05-11 | -$177.00K derived: sum of 2 quarters · filed 2023-05-11 | -$98.00K derived: sum of 3 quarters · filed 2023-05-11 | -$13.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $79.00K derived: sum of 2 quarters · filed 2023-03-06 | $164.00K derived: sum of 3 quarters · filed 2023-03-06 | $245.00K 10-K · filed 2023-03-06 | -$245.00K 10-K · filed 2022-03-07 | |||
| 2021-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $164.00K derived: sum of 2 quarters · filed 2022-11-14 | $245.00K 10-Q · filed 2022-11-14 | -$55.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $166.00K 10-Q · filed 2022-08-15 | -$134.00K derived: sum of 3 quarters · filed 2022-08-15 | -$303.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $81.00K 10-Q · filed 2022-05-16 | -$219.00K derived: sum of 2 quarters · filed 2022-05-16 | -$388.00K derived: sum of 3 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$469.00K derived: sum of 2 quarters · filed 2022-03-07 | -$359.00K 10-K · filed 2022-03-07 | |||||
| 2020-09-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$59.00K 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | $110.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |